The independent, practitioner-led digest, brings together senior marketing leaders from the United States, the United Arab Emirates, and India to examine “The New Marketing OS - Human-led, AI-powered, System-built.” Abu Dhabi, UAE, 24th March 2026: As artificial intelligence begins to reshape how consumers discover, evaluate, and choose brands, a new global digest is exploring a critical … Continue reading The 2026 Edition of the Global Digest ‘State of the Brand’ Highlights Marketing’s Shift from Campaigns to Systems
Day: March 24, 2026
Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
Dubai, 24 March 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Wegovy® HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess body weight and maintain weight reduction long-term. The FDA awarded a Commissioner’s National Priority Voucher for Wegovy® HD, accelerating its review and underscoring its potential to address critical patient … Continue reading Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
uaenews4u.com 